Expression and Initial Mechanism of Nicotinamide Phosphoribosyltransferase (NAMPT) in Dilated Cardiomyopathy
Abstract
To explore nicotinamide phosphoribosyltransferase (NAMPT) expression in dilated cardiomyopathy (DCM) and its initial mechanism in the pathogenesis of DCM. Methods The peripheral blood of 131 Chinese patients with DCM confirmed by West China Hospital of Sichuan University during 2010-2013 were collected. 137 cases of Chinese Han healthy persons who were randomly selected in the physical examination center of West China Hospital of Sichuan University as the control group. The serum NAMPT levels were measured by ELISA. The NAMPT mRNA levels were determined by RT-PCR. Plasmids over-expressing NAMPT and empty vector were constructed and transfected into H9C2 cells. By using WST-1 technique, cell cycle detection and flow cytometry measurements* the effect of NAMPT on H9C2 proliferation and apoptosis was studied. Results Serum NAMPT level was significantly higher in the DCM group compared with that of controls and positively associated with the grade of heart failure and the size of left ventricular in DCM patients. The NAMPT mRNA level was significantly lower in the DCM group than that in the control group. The plasmid over-expressing NAMPT promoted H9C2 cells proliferation and increased the proportion of S phase cells compared with that of empty plasmid group. Over-expressing NAMPT increased proportion of the viable cells and reduced the proportion of late apoptotic and necrotic cells than empty plasmid group in the basic situation or after being treated with different concentrations of H202. Conclusion The high expression of plasma protein level of NAMPT while low expression of NAMPT mRNA in peripheral blood cells, contributes one of the biological characteristics to DCM. The decrease of intracellular NAMPT may be an important factor in the pathogenesis of DCM.
Keywords: NAMPT DCM H9C2 Apoptosis Proliferation
Full Text:
PDFReferences
RONGVAUX A, SHEA RJ.MULKS MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol,2002,32(11):3225-3234.
KITANI T. OKUNO S, FUJISAWA H. Growth phase- dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett, 2003, 544 ( 1/2/3); 74- 78.
CHANG HC. GUARENTE L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab, 2014, 25 ( 3 ); 138- 145.
ZHANG LQ, HERUTH DP, YE SQ. Nicotinamide Phosphoribosyltransferase in Human Diseases. J Bioanal Biomed, 2011,3:13-25.
DOU Q, PENG Y, ZHOU B, et al. Association of nicotinamide phosphoribosyltransferase ( NAMPT ) gene polymorphisms and of serum NAMPT levels with dilated cardiomyopathy in a Chinese population. Int J Mole Sci, 2015,16 (9):22299-22318.
JIASH, LI Y, PARODO J, el al. Pre-B cell colony- enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest,2004 ,113(9) ; 1318-1327.
YESQ, SIMON BA, MALONEY JP. et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Resp Crit Care Med. 2005, 171 (4 ); 361-370.
BRENTANO F, SCHORR O, OSPELT C, et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum, 2007, 56 (9);2829-2839.
TILG H, MOSCHEN AR. Role of adiponectin and PBEF/ visfatin as regulators of inflammation; involvement in obesity- associated diseases. Clin Sci( Lond) ,2008,114(4):275-288.
KOCZAN D, GUTHKE R. THIESEN HJ, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol.2005 .15(4);251 -257.
DAHL ТВ, YNDESTAD A, SKJEI-LAND M. et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis; possible role in inflammation and plaque destabilization. Circulation, 2007, 115(8):972-980.
LAPPEJM, PELFREY CM, TANG WH. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail,2008,14(6) ;521-530.
SAMPIETRO T, NEGLIA D, BIONDA A, et al. Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol,2005,96(12); 1718-1720.
MANN DL, YOUNG JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest,1994,105(3);897-904.
MOSCHEN AR, KASER A, ENRICH B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol,2007,178(3); 1748-1758.
LI J, WANG L, WANG S, et al. The Treg/Thl7 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol ,2010,71(4): 298-303.
GOPAL DM, SAM F. New and emerging biomarkers in left ventricular systolic dysfunction—insight into dilated cardiomyopathy. J Cardiovasc Transl Res, 2013, 6(4); 516- 527.
BOBBERT P, KUHL U, POLLER W, et al. Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy. J Card Fail, 2015,21 (4): 330- 338.
VAN DER VEER E, HO C, O’NEIL C, et al. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem, 2007, 282 ( 15 ); 10841-10845.
WANG В, HASAN MK. ALVARADO E. et al. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene, 2011 30 (8);907-921.
ALCENDOR RR. KIRSHENBAUM LA, IMAI S, et al. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res, 2004, 95 (10);971-980.
REVOLLO JR, KORNER A, MILLS KF, et al. Nampt/ PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab.2007,6(5): 363-375.
KORNER A, GARTEN A, BLUHER M, et al. Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab,2007,92(12) :4783- 4791.
LI Y, ZHANG Y, DORWEILER B, et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem, 2008,283(50);34833-34843.
LIU LY, WANG F, ZHANG XY. et al. Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases. PLoS One,2012,7( 10) :e44933[2017-03-15]. https://doi. org/10. 1371/journal, pone. 0044933.
Refbacks
- There are currently no refbacks.
